From iPSC Disease Modeling to Epigenome Editing: Toward Therapeutic Reversal of Genomic Imprinting Disorders.
How iPSC-based disease modeling is evolving from a platform for mechanism discovery toward a test bed for therapeutic epigenome engineering is discussed and the major challenges that must be addressed are outlined before epigenome editing can be translated to patients with imprinting disorders.